Advancing Antibody Discovery and Vaccine Development with Lipoparticles and Reporter Viruses
Introduction:
Innovative tools have been instrumental for rapid advancements in therapeutic antibody and vaccine research and development. This webinar will focus on critical reagents developed by Integral Molecular, a pioneer in the field of membrane protein and virology research tools.
Lipoparticles are virus-like particles that have been crucial for successful antibody discovery campaigns. Lipoparticles are used to present high-concentration, native-conformation membrane proteins for immunization, antibody screening, and antibody characterization.
Reporter Virus Particles (RVPs) are pseudotyped and virus-like particles that enable consistent, high-throughput studies at BSL-2 conditions for evolving and highly pathogenic viruses
Get the chance to learn about:
- How to use RVPs to generate reproducible virus neutralization assays for clinical and preclinical vaccine development
- Case studies illustrating applications of RVPs in vaccine development and therapeutic research for SARS-CoV-2 and dengue viruses
- How to use Lipoparticles to advance your research involving complex membrane proteins and receptors such as chemokine receptors and GPCRs
Engage in thought-provoking discussions with our experts during the interactive Q&A session
Speaker biography—Christina K. Go, Ph.D.
Dr. Christina K. Go earned her Ph.D. in the biomedical sciences from the Lewis Katz School of Medicine at Temple University studying membrane protein interactions in T cell activation.
Following her dissertation, she completed a research fellowship at the University of Pennsylvania in immunology and infectious diseases. Dr. Go and the Virology group at Integral Molecular specialize in developing tools to accelerate vaccine and therapeutic development for current and emerging viral pathogens.
Speaker biography- Meghan Pitts
Ms. Meghan Pitts graduated from Drexel University and has over ten years of experience working in membrane protein expression and antibody discovery for pre-clinical and clinical applications. Her work has contributed to four peer-reviewed publications. At Integral Molecular, Ms. Pitts supports customers at all stages of their projects from understanding their unique goals to providing reagents and services.